Clinical Trial Update: Neptune Krill Oil (NKO™) in Early Stage Alzheimer's Disease (MNEMOSYNE) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update shows completion of Neptune Krill Oil (NKO) testing in early-stage Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Neptune Krill Oil (NKO) (neptune krill oil)

Snippet

Sponsor: NeuroBioPharm Inc. | Conditions: Early Onset Alzheimer Disease | Phase 4 | Status: COMPLETED